[DISCLOSURE] Boryung Pharmaceutical (003850) reported on July 21 that it has obtained a patent in South Africa for an antihypertensive pharmaceutical composition, a combination of hydrochlorothiazide and fimasartan.
It applied for the patent to gain approval to supply the medicine overseas, Boryung said.
It applied for the patent to gain approval to supply the medicine overseas, Boryung said.